Reactive Arthritis Triggered by Adalimumab and Leflunomide in a Patient with Ankylosing Spondylitis

Reactive arthritis (ReA) is uncommon. The present case is a Chinese man who has been treated with adalimumab and leflunomide to control ankylosing spondylitis (AS). During the treatment, the patient developed a range of symptoms, including fever, fatigue, pustular rash, suppurative urethritis, genit...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Ying, He, Jia, Jiang, Jingjing, Wang, Yujuan, Liu, Ting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9725927/
https://www.ncbi.nlm.nih.gov/pubmed/36483747
http://dx.doi.org/10.2147/CCID.S390918

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9725927/
https://www.ncbi.nlm.nih.gov/pubmed/36483747
http://dx.doi.org/10.2147/CCID.S390918

Ejemplares similares